Mark Alan Goldberg Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Alan Goldberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is a SVP, Product Development in SYNAGEVA BIOPHARMA CORP ($GEVA) and a SVP,Medical&Regulatory Affairs in SYNAGEVA BIOPHARMA CORP ($GEVA).
Address: 128 SPRING STREET, SUITE 520 LEXINGTON 02421 MA
Companies in which Mark Alan Goldberg is an Insider
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Alan Goldberg: SVP,Medical&Regulatory Affairs, SVP, Product Development
Holdings: 0 shares
Latest Transaction: Apr 03 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Alan Goldberg
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP,Medical&Regulat ... | Option Exercise | M | 0.95 | 3,091 | 2,936 | 1,034 | |
| Apr 03 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP,Medical&Regulat ... | Option Exercise | M | 0.95 | 1,325 | 1,259 | 1,926 | |
| Apr 03 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP,Medical&Regulat ... | Sell | S | 54.92 | 619 | 33,995 | 0 | 619 to 0 (-100.00 %) |
| Apr 03 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP,Medical&Regulat ... | Sell | S | 54.21 | 3,797 | 205,835 | 619 | 4.4 K to 619 (-85.98 %) |
| Apr 03 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP,Medical&Regulat ... | Buy | M | 0.95 | 3,091 | 2,936 | 4,416 | 1.3 K to 4.4 K (+233.28 %) |
| Apr 03 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP,Medical&Regulat ... | Buy | M | 0.95 | 1,325 | 1,259 | 1,325 | 0 to 1.3 K |
| Mar 06 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | SVP, Product Develo ... | Option Exercise | M | 0.95 | 4,417 | 4,196 | 3,251 |